FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LASINAVIR
异名/同义词14-OXA-2,8,11-TRIAZAPENTADECANOIC ACID, 4-HYDROXY-9-(1-METHYLETHYL)-7,10-DIOXO-3-(PHENYLMETHYL)-6-((2,3,4-TRIMETHOXYPHENYL)METHYL)-, 1,1-DIMETHYLETHYL ESTER, (3S,4S,6R,9S)-
BMS-234475
CGP-61755
LASINAVIR
LASINAVIR [INN]
LASINAVIR [WHO-DD]
TERT-BUTYL ((.ALPHA.S)-.ALPHA.-((1S,3R)-1-HYDROXY-3-(((1S)-1-((2-METHOXYETHYL)CARBAMOYL)-2-METHYLPROPYL)CARBAMOYL)-4-(2,3,4-TRIMETHOXYPHENYL)BUTYL)PHENETHYL)CARBAMATE
CAS登记号175385-62-3
物质唯一标识(Unique Ingredient Identifier)0QGV8237I3
分子式C35H53N3O9
国际化合物标识(International Chemical Identifier,InChI)BEUUJDAEPJZWHM-COROXYKFSA-N
SMILESC([C@H](C[C@@H]([C@H](Cc1ccccc1)NC(OC(C)(C)C)=O)O)C(N[C@H](C(NCCOC)=O)C(C)C)=O)c2c(OC)c(OC)c(cc2)OC
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System